Vectorite Biomedical Inc. (GTSM:4170) announced a private placement of unsecured domestic convertible bonds on March 13, 2014. The bonds have an issue price of TWD 100,000 each, with a term of three years, and a zero coupon rate.

On the same day, the company announced that the first tranche of the bonds will be issued for proceeds of TWD 500,000,000.

On March 28, 2014, the company amended the transaction. The company will now issue first tranche of the secured domestic convertible bonds for proceeds of TWD 150,000,000. The bonds have an issue price of TWD 100,000 each, with a term of three years, and a zero coupon rate.

On May 26, 2014, the company announced the conversion price of TWD 32.65 per share for first series domestic secured convertible corporate bonds.